U.S., Dec. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07279909) titled 'Phase-III Clinical Studies on Poly Herbal Anti-Diabetic Formulation' on Dec. 01.
Brief Summary: The goal of this clinical trial to learn the clinical efficacy and safety of standardized polyherbal capsule weighing around 500 mg, containing Syzygium cumini, Momordica charantia, Wrightia tinctoria, and Gymnema sylvestre in equal proportions for controlling Diabetic hyperglycemia towards a normal glycemic control. The main question that aims to search is
1. Does the herbal combination formula effective to lower the high blood glucose levels in Type2 diabetics
2. Is the herbal combination therapy is safe for human use
3. Does this tr...